Neumora

Neumora

生物技术研究

Watertown,MA 13,363 位关注者

Pioneering a new era of medicines for brain diseases

关于我们

Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action where we can leverage our precision neuroscience approach. Our pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora is committed to addressing some of the most prevalent brain health disorders and transforming the standard of care for millions of patients living with brain diseases. Learn more about Neumora and career opportunities on our website below.

网站
https://www.neumoratx.com
所属行业
生物技术研究
规模
51-200 人
总部
Watertown,MA
类型
私人持股
创立
2020

地点

  • 主要

    65 Grove Street, Suite 102

    US,MA,Watertown,02472

    获取路线

Neumora员工

动态

相似主页

查看职位

融资

Neumora 共 5 轮

上一轮

补助

US$2,626,569.00

Crunchbase 上查看更多信息